However, a randomized trial conducted by China et al., in patients hospitalized with liver cirrhosis, suggested that daily albumin infusion to preserve a serum albumin level ≥ 3 g/dL did not reveal any benefit in preventing the occurrence of infection, kidney injury, or death [90]. Here, ALB is linked to cirrhosis of liver.